| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $18.3M | $11.0M | $30.1M |
| YoY Revenue Growth % | +66.2% | -63.5% | — |
| Gross Profit | $8.6M | $3.7M | — |
| Gross Margin % | 47.3% | 33.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$39.8M | -$17.2M | -$4.1M |
| Operating Margin % | -80.0% | -80.0% | -13.8% |
| Net Income (GAAP) | -$34.2M | -$21.2M | -$3.3M |
| EBITDA (Normalized) | -$39.2M | -$16.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$31.3M | -$10.1M | -$2.7M |
| Capital Expenditures (CapEx) | $743.0K | $571.0K | — |
| Free Cash Flow (FCF) | -$32.0M | -$10.7M | -$2.7M |
| FCF Margin % | -80.0% | -80.0% | -9.1% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $417.7M | $84.6M | — |
| Total Debt (Short + Long Term) | $989.0K | — | — |
| Total Stockholders' Equity | $461.5M | $76.5M | — |